SLAMF8 as a potential biomarker for rheumatoid arthritis identified by comparing peripheral blood mononuclear cells, fibroblast‐like synoviocytes, and synovial tissue using bioinformatics analysis

Documenti analoghi

• Rapamycin suppresses rheumatoid arthritis fibroblast synovial cell proliferation and induces apoptosis via the AKT/mTORC1 pathway
  di: Shengxiao Zhang, et al.
  Pubblicazione: (2024)
• Pathologically expanded peripheral CD4+PD‐1+Foxp3− T‐cell subset promotes B‐cell hyperactivity in patients with rheumatoid arthritis
  di: Ziran Bai, et al.
  Pubblicazione: (2024)
• Mesenchymal stromal cell therapy for rheumatoid arthritis: Long‐term efficacy, safety, and mechanistic insights
  di: Yingjia Chen, et al.
  Pubblicazione: (2025)
• Artificial intelligence in rheumatoid arthritis research: A bibliometric analysis from 2004 to 2023
  di: Yang Liu, et al.
  Pubblicazione: (2024)
• Genetically supported causal genes for rheumatoid arthritis: Mendelian randomization and co‐localization analyses
  di: Yuanyuan Niu, et al.
  Pubblicazione: (2024)